...) -- Cassava Sciences, Inc. (NASDAQ:SAVA), a clinical-stage biotechnology company...-sellers of the Company's stock. "I have said from the... Cassava Sciences has sold Company stock in over a decade. In... over $100,000,000 shorting SAVA stock. "For a $100 million payday...

...) -- Cassava Sciences, Inc. (NASDAQ:SAVA), a clinical-stage biotechnology company...-sellers of the Company's stock. "I have said from the... Cassava Sciences has sold Company stock in over a decade. In... over $100,000,000 shorting SAVA stock. "For a $100 million payday...

...) -- Cassava Sciences, Inc. (NASDAQ:SAVA), a clinical-stage biotechnology company...-sellers of the Company's stock. "I have said from the... Cassava Sciences has sold Company stock in over a decade. In... over $100,000,000 shorting SAVA stock. "For a $100 million payday...

... those not following Cassava Sciences SAVA- A few days ago the... to validate SAVA's ongoing Ph3 study drug treatment effect. The stock rose... a purchase of $2M in SAVA stock. This is in the context ... the past year, so the stock has been beat up. SAVA stock is up 23% on heavy ... even a token amount of stock that might provide a glimmer ...

... those not following Cassava Sciences SAVA- A few days ago the... to validate SAVA's ongoing Ph3 study drug treatment effect. The stock rose... a purchase of $2M in SAVA stock. This is in the context ... the past year, so the stock has been beat up. SAVA stock is up 23% on heavy ... even a token amount of stock that might provide a glimmer ...

Avxl vs sava Sava insiders buy their stock and believe in the science Avxl dumped their stock and don't believe in their science Avxl insiders ceo and cfo fooled investors Avxl amatuer company

Avxl vs sava Sava insiders buy their stock and believe in the science Avxl dumped their stock and don't believe in their science Avxl insiders ceo and cfo fooled investors Avxl amatuer company

Latest statement for SAVA: Cassava Sciences Responds to Media ...) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company, ...-sellers of the Company’s stock. “I have said from the ... Cassava Sciences has sold Company stock in over a decade. In ... over $100,000,000 shorting SAVA stock. “For a $100 million payday, ...

Latest statement for SAVA: Cassava Sciences Responds to Media ...) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company, ...-sellers of the Company’s stock. “I have said from the ... Cassava Sciences has sold Company stock in over a decade. In ... over $100,000,000 shorting SAVA stock. “For a $100 million payday, ...

So does the SAVA news help, or hurt our stock?

So does the SAVA news help, or hurt our stock?

Cassava Sciences stock jumps 10% after director buys $860K shares In a regulatory filing, Cassava Sciences (NASDAQ:SAVA) disclosed that its director Richard Barry bought 36.16K shares of common stock at $23.79 on Aug.23 for a total outlay of $860K. The move leaves Richard Barry with ownership of 186,159 shares.

Cassava Sciences stock jumps 10% after director buys $860K shares In a regulatory filing, Cassava Sciences (NASDAQ:SAVA) disclosed that its director Richard Barry bought 36.16K shares of common stock at $23.79 on Aug.23 for a total outlay of $860K. The move leaves Richard Barry with ownership of 186,159 shares.

unjustified stock price on Anavex based on the fundamentals which are above par (trial data).......the shorts and market sentiment own this for now and sava.......what a pity!

unjustified stock price on Anavex based on the fundamentals which are above par (trial data).......the shorts and market sentiment own this for now and sava.......what a pity!